LA JOLLA, CA—La Jolla Institute for Immunology (LJI) has been selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H).
Based in the Greater Boston area and managed by VentureWell, the Investor Catalyst Hub seeks to accelerate the commercialization of groundbreaking and accessible biomedical solutions. It utilizes an innovative hub-and-spoke model designed to reach a wide range of nonprofit organizations and Minority-Serving Institutions, with the ultimate aim of delivering scalable healthcare outcomes for all Americans.
![The Investor Catalyst Hub will facilitate novel research findings and future-forward ideas to advance commercialization, affordability, and revolutionary breakthroughs to achieve improved health outcomes for all Americans. Credit: ARPA-H.](https://www.lji.org/wp-content/uploads/2024/09/ARPA-H-Catalyst-Network.jpg)
The Investor Catalyst Hub will facilitate novel research findings and future-forward ideas to advance commercialization, affordability, and revolutionary breakthroughs to achieve improved health outcomes for all Americans. Credit: ARPA-H.
“LJI is proud to serve as a spoke in the Investor Catalyst Hub,” says LJI President, CEO, and Professor Erica Ollmann Saphire, Ph.D., MBA. “LJI scientists are innovating vaccine design and advancing new therapies for cancer, autoimmune disease, allergies, and infectious disease. We hope our contributions to this nationwide effort will lead to better health for all.”
LJI joins a dynamic nationwide network of organizations aligned to ARPA-H’s overarching mission to improve health outcomes through the following research focus areas: health science futures, proactive health, scalable solutions, and resilient systems. Investor Catalyst Hub spokes represent a broad spectrum of expertise, geographic diversity, and community perspectives.
“Our spoke network embodies a rich and representative range of perspectives and expertise,” says Mark Marino, Vice President of Growth Strategy and Development for VentureWell and Project Director for the Investor Catalyst Hub. “Our spokes comprise a diverse network that will be instrumental in ensuring that equitable health solutions reach communities across every state and tribal nation.”
As an Investor Catalyst Hub spoke, LJI gains access to potential funding and flexible contracting for faster award execution compared to traditional government contracts. Spoke membership also offers opportunities to provide input on ARPA-H challenge areas and priorities, along with access to valuable networking opportunities and a robust resource library.
The spoke network will continue to grow as the Investor Catalyst Hub expands its efforts, with applications being selected on a rolling basis. Interested organizations can visit https://investorcatalysthub.org/ to learn more or submit a membership application.
###
About La Jolla Institute
The La Jolla Institute for Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading toward its goal: life without disease. Visit lji.org for more information.